Compare Bremelanotide (evidence A) and PT-141 (evidence A) on mechanism, clinical status, safety, and dosing.
Bremelanotide is a 7-amino-acid cyclic melanocortin peptide (MW ~1025.2 g/mol) that acts as an agonist at melanocortin receptors MC4R and MC3R. It was…
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide and non-selective melanocortin receptor agonist (MC3R/MC4R) derived as an active metabolite of…
Full profiles: Bremelanotide, PT-141.